These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 10772947)

  • 1. Characterization of rat OX40 ligand by monoclonal antibody.
    Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of rat OX40 ligand by molecular cloning.
    Akiba H; Atsuta M; Yagita H; Okumura K
    Biochem Biophys Res Commun; 1998 Oct; 251(1):131-6. PubMed ID: 9790919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand.
    al-Shamkhani A; Birkeland ML; Puklavec M; Brown MH; James W; Barclay AN
    Eur J Immunol; 1996 Aug; 26(8):1695-9. PubMed ID: 8765008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
    Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
    Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
    Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
    Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of OX40-OX40 ligand interactions in langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice.
    Sato T; Ishii N; Murata K; Kikuchi K; Nakagawa S; Ndhlovu LC; Sugamura K
    Eur J Immunol; 2002 Nov; 32(11):3326-35. PubMed ID: 12555678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and function of OX40 ligand on human dendritic cells.
    Ohshima Y; Tanaka Y; Tozawa H; Takahashi Y; Maliszewski C; Delespesse G
    J Immunol; 1997 Oct; 159(8):3838-48. PubMed ID: 9378971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
    Mendel I; Shevach EM
    Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial cells provide T cells with costimulatory signals via the OX40/gp34 system.
    Kunitomi A; Hori T; Imura A; Uchiyama T
    J Leukoc Biol; 2000 Jul; 68(1):111-8. PubMed ID: 10914497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis.
    Totsuka T; Kanai T; Uraushihara K; Iiyama R; Yamazaki M; Akiba H; Yagita H; Okumura K; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G595-603. PubMed ID: 12631559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.
    Harrop JA; Reddy M; Dede K; Brigham-Burke M; Lyn S; Tan KB; Silverman C; Eichman C; DiPrinzio R; Spampanato J; Porter T; Holmes S; Young PR; Truneh A
    J Immunol; 1998 Aug; 161(4):1786-94. PubMed ID: 9712045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein.
    Higgins LM; McDonald SA; Whittle N; Crockett N; Shields JG; MacDonald TT
    J Immunol; 1999 Jan; 162(1):486-93. PubMed ID: 9886424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of OX40 ligand into lymphoma cells elicits anti-lymphoma immunity in vivo.
    Kaneko H; Hori T; Yanagita S; Kadowaki N; Uchiyama T
    Exp Hematol; 2005 Mar; 33(3):336-43. PubMed ID: 15730857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of OX40 expressed on human CD8+ T cells.
    Fujita T; Ukyo N; Hori T; Uchiyama T
    Immunol Lett; 2006 Jul; 106(1):27-33. PubMed ID: 16750861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNA.
    Mestas J; Crampton SP; Hori T; Hughes CC
    Int Immunol; 2005 Jun; 17(6):737-47. PubMed ID: 15908450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid induction of OX40 ligand on primary T cells activated under DNA-damaging conditions.
    Kondo K; Okuma K; Tanaka R; Matsuzaki G; Ansari AA; Tanaka Y
    Hum Immunol; 2008 Sep; 69(9):533-42. PubMed ID: 18718855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of tumour necrosis factor (TNF) receptor/ligand superfamily co-stimulatory molecules CD40, CD30L, CD27L, and OX40L in murine hearts with chronic ongoing myocarditis caused by coxsackie virus B3.
    Seko Y; Takahashi N; Oshima H; Shimozato O; Akiba H; Kobata T; Yagita H; Okumura K; Azuma M; Yazaki Y
    J Pathol; 1999 Aug; 188(4):423-30. PubMed ID: 10440754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis.
    Akiba H; Miyahira Y; Atsuta M; Takeda K; Nohara C; Futagawa T; Matsuda H; Aoki T; Yagita H; Okumura K
    J Exp Med; 2000 Jan; 191(2):375-80. PubMed ID: 10637281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.